FreeTheAI

Propanc Biopharma Inc

PPCB · NASDAQ · USD

$0.4812

+0.0102 2.17%todayNot financial advice.

PPCB Price chart 5D
Open
0.4956
Day range
0.4621 - 0.4956
52-week range
0.4600 - 47.50
Volume
45.72K
Market cap
4.73M
P/E ratio
—
EPS
-25.81
Dividend yield
0.00%
Beta
2.44

Performance

W

−4.88%

1M

−52.36%

3M

−72.54%

6M

−81.38%

YTD

−96.44%

Y

−98.98%

5Y

−100.00%

All

−100.00%

In the news

  1. Oct 7

    Propanc Biopharma Reports Preclinical Pancreatic Cancer Data, Targets Q1 2027 Trial Start

    Propanc Biopharma released preclinical data for its pancreatic cancer treatment PRP and plans to launch a Phase 1b clinical trial in early 2027.

    Company news

Embed on your site

Embed docs

Add a live price card or a chart to any page. Free, no sign-up; cards refresh every minute and link back here.

<iframe src="https://stocks.freetheai.org/embed/NASDAQ-PPCB" width="340" height="170" style="border:0;max-width:100%" loading="lazy" title="Propanc Biopharma Inc (PPCB) - FreeTheAI Stocks"></iframe>
<p style="font-size:12px"><a href="https://stocks.freetheai.org/symbols/NASDAQ-PPCB">PPCB stock price</a> by FreeTheAI Stocks</p>